214 related articles for article (PubMed ID: 21097718)
21. Praja2 suppresses the growth of gastric cancer by ubiquitylation of KSR1 and inhibiting MEK-ERK signal pathways.
Zhao Z; Zhu L; Xing Y; Zhang Z
Aging (Albany NY); 2021 Jan; 13(3):3886-3897. PubMed ID: 33461174
[TBL] [Abstract][Full Text] [Related]
22. Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines.
Keller S; Zwingenberger G; Ebert K; Hasenauer J; Wasmuth J; Maier D; Haffner I; Schierle K; Weirich G; Luber B
Mol Oncol; 2018 Apr; 12(4):441-462. PubMed ID: 29325228
[TBL] [Abstract][Full Text] [Related]
23. Disruption of the EGFR E884-R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity.
Tang Z; Jiang S; Du R; Petri ET; El-Telbany A; Chan PS; Kijima T; Dietrich S; Matsui K; Kobayashi M; Sasada S; Okamoto N; Suzuki H; Kawahara K; Iwasaki T; Nakagawa K; Kawase I; Christensen JG; Hirashima T; Halmos B; Salgia R; Boggon TJ; Kern JA; Ma PC
Oncogene; 2009 Jan; 28(4):518-33. PubMed ID: 19015641
[TBL] [Abstract][Full Text] [Related]
24. Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients.
Wang N; She J; Liu W; Shi J; Yang Q; Shi B; Hou P
Cell Cycle; 2015; 14(5):732-43. PubMed ID: 25590580
[TBL] [Abstract][Full Text] [Related]
25. Map2k4δ - identification and functional characterization of a novel Map2k4 splice variant.
Haeusgen W; Tueffers L; Herdegen T; Waetzig V
Biochim Biophys Acta; 2014 May; 1843(5):875-84. PubMed ID: 24487067
[TBL] [Abstract][Full Text] [Related]
26. Occurrence of low frequency PIK3CA and AKT2 mutations in gastric cancer.
Zhang QY; Cheng WX; Li WM; Au W; Lu YY
Mutat Res; 2014 Nov; 769():108-12. PubMed ID: 25771729
[TBL] [Abstract][Full Text] [Related]
27. Human Epidermal Growth Factor Receptor-2 Promotes Invasion and Metastasis in Gastric Cancer by Activating Mitogen-activated Protein Kinase Signaling.
Hou F; Shi DB; Chen YQ; Gao P
Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):529-534. PubMed ID: 29734245
[TBL] [Abstract][Full Text] [Related]
28. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors.
Hoshino R; Chatani Y; Yamori T; Tsuruo T; Oka H; Yoshida O; Shimada Y; Ari-i S; Wada H; Fujimoto J; Kohno M
Oncogene; 1999 Jan; 18(3):813-22. PubMed ID: 9989833
[TBL] [Abstract][Full Text] [Related]
29. Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization.
Takada H; Imoto I; Tsuda H; Sonoda I; Ichikura T; Mochizuki H; Okanoue T; Inazawa J
Cancer Sci; 2005 Feb; 96(2):100-10. PubMed ID: 15723654
[TBL] [Abstract][Full Text] [Related]
30. YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling.
Zhang C; Lin X; Zhao Q; Wang Y; Jiang F; Ji C; Li Y; Gao J; Li J; Shen L
J Cancer Res Clin Oncol; 2020 Feb; 146(2):329-342. PubMed ID: 31912229
[TBL] [Abstract][Full Text] [Related]
31. Novel members of the mitogen-activated protein kinase activator family in Xenopus laevis.
Yashar BM; Kelley C; Yee K; Errede B; Zon LI
Mol Cell Biol; 1993 Sep; 13(9):5738-48. PubMed ID: 8395011
[TBL] [Abstract][Full Text] [Related]
32. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
Zhou J; Chen Q
FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
[TBL] [Abstract][Full Text] [Related]
33. DNA Methylation and Genetic Aberrations in Gastric Cancer.
Usui G; Matsusaka K; Mano Y; Urabe M; Funata S; Fukayama M; Ushiku T; Kaneda A
Digestion; 2021; 102(1):25-32. PubMed ID: 33070127
[TBL] [Abstract][Full Text] [Related]
34. Difference of molecular alterations in HER2-positive and HER2-negative gastric cancers by whole-genome sequencing analysis.
Zhou C; Feng X; Yuan F; Ji J; Shi M; Yu Y; Zhu Z; Zhang J
Cancer Manag Res; 2018; 10():3945-3954. PubMed ID: 30310315
[TBL] [Abstract][Full Text] [Related]
35. Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines.
Ebert K; Zwingenberger G; Barbaria E; Keller S; Heck C; Arnold R; Hollerieth V; Mattes J; Geffers R; Raimúndez E; Hasenauer J; Luber B
BMC Cancer; 2020 Oct; 20(1):1039. PubMed ID: 33115415
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of ZFX inhibits gastric cancer cell growth in vitro and in vivo via downregulating the ERK-MAPK pathway.
Wu S; Lao XY; Sun TT; Ren LL; Kong X; Wang JL; Wang YC; Du W; Yu YN; Weng YR; Hong J; Fang JY
Cancer Lett; 2013 Sep; 337(2):293-300. PubMed ID: 23587796
[TBL] [Abstract][Full Text] [Related]
37. Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer.
Hou Q; Wu YH; Grabsch H; Zhu Y; Leong SH; Ganesan K; Cross D; Tan LK; Tao J; Gopalakrishnan V; Tang BL; Kon OL; Tan P
Cancer Res; 2008 Jun; 68(12):4623-30. PubMed ID: 18559507
[TBL] [Abstract][Full Text] [Related]
38. Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways.
Wang H; Lu J; Tang J; Chen S; He K; Jiang X; Jiang W; Teng L
BMC Cancer; 2017 Mar; 17(1):191. PubMed ID: 28292264
[TBL] [Abstract][Full Text] [Related]
39. Molecular context of the EGFR mutations: evidence for the activation of mTOR/S6K signaling.
Conde E; Angulo B; Tang M; Morente M; Torres-Lanzas J; Lopez-Encuentra A; Lopez-Rios F; Sanchez-Cespedes M
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):710-7. PubMed ID: 16467080
[TBL] [Abstract][Full Text] [Related]
40. Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma.
Byun DS; Cho K; Ryu BK; Lee MG; Park JI; Chae KS; Kim HJ; Chi SG
Int J Cancer; 2003 Apr; 104(3):318-27. PubMed ID: 12569555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
